Thyroxine, at a physiological concentration, is able to interfere with resveratrol-induced antiproliferation by inhibiting serine phosphorylation of p53 and blocking resveratrol-induced cancer cell apoptosis [35]. The gene discussed is TP53; the disease is cancer.